Study guide

Abnormal bleeding and structural causes

AMC CAT MCQ Examination AMC Part 1

Track your progress as you read

Finished sections get a check mark.

1 Acute Coronary Syndromes & ECG Localization

ACS recognition and ECG localisation Reperfusion and infarction complications

2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias

Heart failure assessment and treatment Arrhythmias and conduction emergencies

3 Systemic Hypertension & Peripheral Vascular Disease

Blood pressure and cardiovascular risk Secondary hypertension and arterial disease

4 Valvular Heart Disease, Infective Endocarditis & Pericarditis

Aortic and mitral valve disease Endocarditis and pericardial emergencies

5 Asthma & COPD Acute Flares and Maintenance

Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations

6 Pneumonia, pleural disease and respiratory failure

Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis

7 GI bleeding, bowel inflammation and malabsorption

GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS

8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis

Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance

9 Diabetes, thyroid and adrenal disease

Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease

10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies

AKI and chronic kidney disease Potassium and sodium emergencies

11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment

Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care

12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis

Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia

13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology

Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms

14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis

Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment

15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries

Trauma primary survey and adjuncts Chest trauma and immediate threats

16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance

Head injury, imaging and haemorrhage Herniation and spinal cord injury

17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome

Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury

18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care

Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus

19 Aortic Aneurysms & Acute Arterial Limb Ischaemia

Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia

20 Urological Emergencies, Testicular Torsion & Haematuria Investigation

Retention, stones and obstructed infection Scrotal pain and haematuria

21 Preoperative Risk Stratification & Postoperative Surgical Complications

Preoperative assessment and medicines Postoperative complications and prevention

22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening

Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons

23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy

Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding

24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies

Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth

25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis

Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care

26 Contraception, Emergency Contraception & Pregnancy Termination

Contraceptive choice and missed pills Emergency contraception and abortion

27 Australian Cervical Screening Program & Gynaecological Malignancies

Cervical screening and cervical cancer Endometrial and ovarian cancer

28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice

Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening

29 Developmental Milestones, Growth Charts & Failure to Thrive

Developmental milestones Regression, autism and support Faltering growth and developmental comparisons

30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions

Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons

31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis

Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis

32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease

Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up

33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury

Pyloric stenosis Intussusception and dehydration Child protection and injury assessment

34 The Mental State Examination & Suicide Risk Stratification

Mental state examination and psychotic symptoms Suicide formulation and mental health law

35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers

Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT

36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder

Anxiety, panic and agoraphobia OCD and trauma-related disorders

37 Schizophrenia, Acute Psychosis & Antipsychotic Management

Psychosis assessment and antipsychotics Clozapine and severe adverse effects

38 Substance Use Disorders & Acute Withdrawal Syndromes

Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants

39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry

Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry

40 Medicare, PBS, AHPRA & Good Medical Practice Framework

Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications

41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment

Consent, material risks and young people Capacity, refusal and substitute decisions

42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications

Privacy, disclosure and child reporting Driving fitness and threat disclosure

43 First Nations health and preventive care

First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention

44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases

Epidemiology, calculations, bias and surveillance

45 Neurological presentations

Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness

46 Musculoskeletal pain

Back, neck, bone and soft tissue pain

47 Eye presentations

Altered vision and retinal disease Red eye, ocular injury and discharge

48 Ear, nose, throat and oral health

Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis

49 Skin, hair and nails

Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities

50 Breast health and feeding

Breast lumps, discharge and breastfeeding problems

51 Sexual and reproductive presentations

Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction

52 Palliative care and carers

The dying patient, symptoms and carers

53 Eating disorders and personality care

Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care

54 Sleep presentations

Insomnia, snoring and daytime sleepiness

55 Poisoning, resuscitation and environmental emergencies

Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning

56 Communication, rights and professional practice

Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health

57 Genetics, research and donation

Genetic testing, research and organ donation

58 Travel, fever and outbreaks

Fever, travellers and outbreak response

Abnormal bleeding and structural causes

Key Takeaways Explain This Topic AI

PALM–COEIN distinguishes structural from non-structural bleeding causes.

Pregnancy testing is important in reproductive-age bleeding presentations.

Symptoms and fertility goals influence treatment of fibroids and adenomyosis.

Last updated: October 2026

Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis

Abnormal uterine bleeding (AUB) and chronic pelvic pain represent frequent presentations in Australian general practice and gynaecological outpatient clinics. A structured clinical approach requires distinguishing structural uterine pathologies from systemic and endocrinological disorders, stratifying oncological risk, and delivering evidence-based medical and surgical therapies.

FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding

The International Federation of Gynecology and Obstetrics (FIGO) PALM-COEIN system classifies abnormal uterine bleeding into nine distinct categories. The first four categories represent structural abnormalities that can be imaged or sampled histologically ( PALM ), whereas the remaining five represent non-structural systemic, endocrine, or functional disturbances ( COEIN ).

Structural Etiologies (PALM)

Polyp (AUB-P) : Endometrial or endocervical polyps are focal hyperplastic outgrowths of endometrial glands and stroma containing thick-walled vascular channels. While most are benign, atypical hyperplasia or malignancy occurs in approximately 1% to 3% of premenopausal and 4% to 5% of postmenopausal patients. Transvaginal ultrasound (TVUS) or saline infusion sonohysterography (SIS) demonstrates a well-defined intracavitary lesion with a solitary vascular feeding pedicle on colour Doppler. Management consists of hysteroscopic polypectomy with histological examination.

Adenomyosis: Ultrasound assesses myometrial features; MRI can evaluate the junctional zone. A thickness above about 12 mm is an MRI feature, not a stand-alone universal ultrasound definition.

Leiomyoma (AUB-L) : Benign monoclonal smooth muscle neoplasms of the myometrium (fibroids), subdivided by the FIGO subclassification based on anatomical position (Types 0 to 8):

Submucosal (Types 0, 1, 2) : Lie directly beneath or distort the endometrium; even small submucosal lesions disrupt endometrial haemostasis and produce profound menorrhagia and subfertility.

FIGO locations: Types 3 and 4 are intramural; type 3 contacts the endometrium. Type 5 is subserosal with at least half its diameter intramural, type 6 has less than half intramural and type 7 is pedunculated subserosal.

Subserosal (Types 6, 7) : Project outward from the peritoneal surface; typically cause compressive bulk symptoms (urinary frequency, constipation, hydronephrosis) rather than abnormal bleeding.

Medical management : Tranexamic acid, combined oral contraceptives (COCP), oral progestogens, or LNG-IUS for menorrhagia. Gonadotrophin-releasing hormone (GnRH) agonists (goserelin) or antagonists (relugolix) induce temporary hypoestrogenism, reducing fibroid volume by 30% to 50% prior to surgery or in perimenopausal transition.

Surgical management : Hysteroscopic resection for Type 0 and 1 submucosal fibroids; laparoscopic or open abdominal myomectomy for women desiring future fertility; uterine artery embolisation (UAE) or hysterectomy for definitive management in completed families.

Malignancy & Hyperplasia (AUB-M) : Encompasses endometrial hyperplasia (with or without cytological atypia) and endometrial carcinoma. Atypical endometrial hyperplasia carries a 30% to 45% risk of concurrent invasive adenocarcinoma on definitive hysterectomy specimen.

Non-Structural Etiologies (COEIN)

Coagulopathy (AUB-C) : Encompasses systemic disorders of haemostasis, notably von Willebrand disease (vWD), platelet function defects, and immune thrombocytopenia. Up to 20% of adolescents presenting with severe menorrhagia requiring hospital admission have an underlying coagulopathy. Clinical screening criteria include heavy bleeding since menarche, personal history of postpartum haemorrhage or surgical bleeding, frequent epistaxis, or bleeding gums.

Ovulatory Dysfunction (AUB-O) : Common at the extremes of reproductive life (adolescence and perimenopause) and in endocrinopathies such as polycystic ovary syndrome (PCOS), hypothyroidism, and hyperprolactinaemia. Anovulation results in persistent, unopposed oestrogen stimulation of the endometrium without corpus luteum formation or progesterone production. The endometrium outgrows its vascular supply, leading to erratic, unpredictable, and often profuse breakthrough bleeding.

Endometrial Primary Dysfunction (AUB-E) : Manifests as cyclic, predictable, heavy menstrual bleeding in women with normal ovulatory cycles and no identifiable structural lesion. The primary defect involves local endometrial haemostasis, including deficient production of vasoconstrictors (prostaglandin P G F 2 α PGF_{2\alpha} PG F 2 α ​ and endothelin-1), excessive production of vasodilators (prostaglandin P G E 2 PGE_2 PG E 2 ​ and prostacyclin), or accelerated tissue plasminogen activator (tPA)-mediated fibrinolysis.

Iatrogenic (AUB-I) : Caused by therapeutic interventions, including copper intrauterine devices, breakthrough bleeding from progestogen-only implants or depot injections, systemic anticoagulants, selective serotonin reuptake inhibitors, or herbal supplements.

Not Otherwise Classified (AUB-N) : Rare conditions such as uterine arteriovenous malformations (AVMs), chronic endometritis, and cesarean scar defects (isthmocele) that do not fit into other categories.

Diagnostic Workup and Endometrial Biopsy Thresholds

The diagnostic algorithm for abnormal uterine bleeding begins with a targeted clinical history, physical examination, and mandatory exclusion of pregnancy in all women of reproductive age via urine or serum human chorionic gonadotrophin ( β \beta β -hCG).

Laboratory and Imaging Evaluation

Full Blood Count & Ferritin : Assesses the severity of iron deficiency anaemia secondary to chronic heavy blood loss.

Coagulation Studies : Indicated in adolescents with severe menorrhagia, patients with a personal or family history of bleeding disorders, or prior to invasive surgical procedures.

Endocrine Biomarkers : Thyroid-stimulating hormone (TSH), prolactin, and androgen profile (free testosterone, sex hormone-binding globulin) indicated when ovulatory dysfunction or PCOS is suspected.

Pelvic Transvaginal Ultrasound (TVUS) : The initial imaging modality of choice to evaluate endometrial stripe thickness, endometrial texture, myometrial homogeneity, junctional zone integrity, and ovarian morphology. Saline infusion sonohysterography (SIS) or outpatient hysteroscopy is indicated if the endometrium is thickened, heterogeneous, or if intracavitary polyps or submucosal fibroids are suspected.

Primary references (checked 7 October 2026): 2023 international PCOS guideline .